# Browndove Healthcare Pvt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/browndove-healthcare-pvt

- Industry: Medical Devices & Equipment
- Headquarters: Bangalore, India
- Website: www.browndove.com
- Total disclosed funding: $2.6M
- Latest round: Series A (Dec 2, 2015)
- Investors on record: 1

## About

Browndove Healthcare Pvt Ltd focuses on developing renal care medical devices and consumables, effectively supporting patients undergoing dialysis and other renal therapies with high-quality, reliable solutions.Browndove Healthcare Pvt Ltd, founded in 1996 and headquartered in Bangalore, India, specializes in renal care solutions, including dialysers and blood tubing sets. The company has not undergone significant changes in business strategy or operations since its inception. Its founder has a history in the medical device sector, although specific details about previous ventures are not available. Browndove Healthcare raised a total of INR 100 million in its Series B funding round on May 30, 2019, which constitutes the complete amount raised to date, with a current valuation of INR 1,114.585 mn.Browndove Healthcare specializes in a comprehensive range of renal care medical devices and consumables designed to support patients undergoing dialysis and other renal therapies. Their core product offerings include dialysers, blood tubing sets, AV fistula needles, transducer protectors, and catheters. These products are critical in ensuring effective dialysis treatment, which helps to filter waste and excess fluids from the blood of individuals suffering from kidney failure. Tailored specifically for the healthcare community, Browndove's products are manufactured in a certified facility in Harohalli, Bengaluru, adhering to stringent quality standards. The company primarily serves hospitals, clinics, and dialysis centers across India and international markets, focusing on regions that require reliable renal care solutions.Browndove Healthcare generated revenue of INR 11,682,560 in the most recent year, 2023, with an EBITDA of INR -1,296,214. The company engages primarily in B2B transactions with healthcare institutions such as hospitals and dialysis centers, driving sales through bulk purchases of their flagship products, including blood tubing sets and dialysers. They offer custom configurations for certain products to meet the specific needs of their clients, ensuring adaptability within their service offerings.Browndove Healthcare intends to leverage the funding raised in May 2019 to support the design and launch of new renal care products. The company is also planning to expand into new geographic regions, particularly targeting markets in Southeast Asia and the Middle East, aiming for entry by the end of 2024. These initiatives will be crucial in strengthening their market presence and enhancing their product offerings.

## Funding rounds

- Series A, Dec 2, 2015, $2.6M — Somerset Indus Capital Partners

## Investors

- Somerset Indus Capital Partners (https://capitalatlas.ai/funds/somerset-indus-capital-partners) — Series A